Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT07658755)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT07658755 Sponsor: Hospital General Universitario Gregorio Marañon Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07658755 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged between 50 and 75 years old (inclusive)
People who have had a routine blood test done through the Clinical Biochemistry Laboratory at Hospital General Universitario Gregorio Marañón, ordered by a primary care doctor from one of the 11 linked primary care centres in the SERMAS network
People whose blood test results show at least one of the following combinations of health markers: (1) a liver enzyme called ALT above the normal range AND a blood sugar measure (HbA1c) of 6.5% or higher; OR (2) ALT above the normal range AND a body mass index (BMI) over 30; OR (3) a BMI over 30 AND an HbA1c of 6.5% or higher

Who may not be able to join:

People younger than 50 or older than 75 years of age
People already known to have a liver condition, such as significant liver scarring, cirrhosis, liver cancer, or those who have previously had a liver transplant
People who have already had a liver scarring (fibrosis) assessment done within the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rafael Bañares, Full-Professor of Medicine, Universidad Complutense de Madrid, President of Spanish Association for the Study of the Liver (AEEH)

Phone: +34 91 586 8308

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07658755

Sponsor: Hospital General Universitario Gregorio Marañon

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: +34 91 586 8308

More information: https://clinicaltrials.gov/study/NCT07658755

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged between 50 and 75 years old (inclusive)
People who have had a routine blood test done through the Clinical Biochemistry Laboratory at Hospital General Universitario Gregorio Marañón, ordered by a primary care doctor from one of the 11 linked primary care centres in the SERMAS network
People whose blood test results show at least one of the following combinations of health markers: (1) a liver enzyme called ALT above the normal range AND a blood sugar measure (HbA1c) of 6.5% or higher; OR (2) ALT above the normal range AND a body mass index (BMI) over 30; OR (3) a BMI over 30 AND an HbA1c of 6.5% or higher

Who may not be able to join:

People younger than 50 or older than 75 years of age
People already known to have a liver condition, such as significant liver scarring, cirrhosis, liver cancer, or those who have previously had a liver transplant
People who have already had a liver scarring (fibrosis) assessment done within the past 12 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Hospital General Universitario Gregorio Marañon

Registry

ClinicalTrials.gov

Start date

1 October 2024

Est. completion

1 June 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Prevalence of hepatic fibrosis detected by the automated single-step case-finding strategy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov